The ImmunoCARE Study
Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Info via tweet from one of the researchers:
Eligible participants will receive 10 @CueHealth tests per month as well as access to Cue's on-demand telehealth and prescription delivery services at no cost.
These tests are much more sensitive than antigen tests.
Info from the website:
About the Study
The risks associated with COVID-19 infection are higher for immunocompromised individuals than the general public. ImmunoCARE is an innovative research project to study whether repeated at-home tests, on-demand telemedicine, and quick delivery of medication for those who test positive for COVID-19 can reduce COVID-19 severity in immunocompromised people.
ImmunoCARE is a joint research project from Scripps Research – a renowned biomedical research organization — and Cue Health, a leading health care technology company that develops portable diagnostic tests for at-home use.
Who Can Enroll
ImmunoCARE is available to individuals who are moderately to severely immunocompromised. Participants will provide documentation from a medical provider confirming their diagnosis.
Additional inclusion criteria includes:
Living in the United States
18 years or older
Vaccinated against COVID-19
Willing and able to participate in study interventions including:
Use of a compatible smartphone, including camera and bluetooth
Willing and able to share health insurance claims data from Medicaid, Medicare, or an Anthem plan
Completing Surveys
Use of Cue Health App and tests
Use of MyDataHelps by Web or App
Immunocompromised, including
Symptomatic HIV
Graft versus host disease
Immunoglobulin deficiency/Immunodeficiency
Immunosuppressive therapy
Leukemia
Lymphoma (Hodgkin or non-Hodgkin)
Metastatic Cancer
Multiple Myeloma
Solid organ malignancy
Transplant, hematopoietic stem cell
Transplant, solid organ
What We Will Ask You to Do
ImmunoCARE will enroll 10,000 participants. Half of participants will test for COVID-19 and seek care as they normally would; the other half will receive at-home COVID-19 tests from Cue Health for themselves and others in their household. All participants will be asked to complete monthly surveys about COVID-19 exposure, infection, and hospitalization.
Our Thanks to You
As our thanks for your participation, all eligible participants will receive a series of Amazon gift cards as compensation for time throughout the study.
